The protective effect of ebselen on radiocontrast-induced nephrotoxicity

Renal Failure

Volumn 34, Issue 8, 2012, Pages 991-997

  Ozgur, Tumay ^a   Tutanc, Murat ^a   Zararsiz, Ismail ^b   Motor, Sedat ^a   Ozturk, Oktay Hasan ^a   Yaldiz, Mehmet ^a   Kurtgoz, Ozgur Yildirim ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b MEVLANA UNIVERSITY   (Turkey)

Author keywords

Ebselen; Nephrotoxicity; Protective effect; Radiocontrast; Rats

Indexed keywords

ANTIOXIDANT; CATALASE; CONTRAST MEDIUM; CREATININE; EBSELEN; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; OXIDIZING AGENT; SUPEROXIDE DISMUTASE; URIC ACID;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DETERIORATION; DRUG MECHANISM; ENZYME ACTIVITY; HISTOLOGY; HISTOPATHOLOGY; INCIDENCE; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; UREA BLOOD LEVEL;

ACUTE KIDNEY INJURY; ANIMALS; ANTIOXIDANTS; AZOLES; CONTRAST MEDIA; KIDNEY; KIDNEY DISEASES; MALE; ORGANOSELENIUM COMPOUNDS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84865266098     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.706880     Document Type: Article

References (37)

1. Huber W, Ilgmann K, Page M, et al. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: Controlled, randomized, double-blinded study. Radiology. 2002;223:772-779.
2. Bakris GL, Lass N, Gaber AO, Jones JD, Burnett JC, Jr. Radiocontrast medium-induced declines in renal function: A role for oxygen free radicals. Am J Physiol. 1990;258:115-120.
3. Zager RA, Johnson AC, Hanson SY. Radiographic contrast media-induced tubular injury: Evaluation of oxidant stress and plasma membrane integrity. Kidney Int. 2003;64:128-139.
4. Heyman SN, Rosen S, Khamaisi M, Idee JM, Rosenberger C. Reactive oxygen species and the pathogenesis of radiocontrastinduced nephropathy. Invest Radiol. 2010;45:188-195.
5. Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis. 1997;29:465-477.
6. Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol. 2000;11:177-182.
7. Noguchi N, Yoshida Y, Kaneda H, Yamamoto Y, Niki E. Action of ebselen as an antioxidant against lipid peroxidation. Biochem Pharmacol. 1992;44:39-44.
8. Schewe T. Molecular actions of ebselen - An antiinflammatory antioxidant. Gen Pharmacol. 1995;26:1153-1169.
9. Sies H, Masumoto H. Ebselen as a glutathione peroxidase mimic and as a scavenger of peroxynitrite. Adv Pharmacol. 1997;38:229-246.
10. Noiri E, Nakao A, Uchida K, et al. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol. 2001;281:948-957.
11. Yoshida M, Iizuka K, Terada A, et al. Prevention of nephrotoxicity of cisplatin by repeated oral administration of ebselen in rats. Tohoku J Exp Med. 2000;191:209-220.
12. Baldew GS, McVie JG, van der Valk MA, Los G, de Goeij JJ, Vermeulen NP. Selective reduction of cis-diamminedichloroplatinum (ii) nephrotoxicity by ebselen. Cancer Res. 1990;50: 7031-7036.
13. Yenicerioglu Y, Yilmaz O, Sarioglu S, et al. Effects of nacetylcysteine on radiocontrast nephropathy in rats. Scand J Urol Nephrol. 2006;40:63-69.
14. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990;186:407-421.
15. Aebi H. Catalase. New York: Academic Press; 1974:673-677.
16. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158-169.
17. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497-500.
18. Jost G, Pietsch H, Sommer J, et al. Retention of iodine and expression of biomarkers for renal damage in the kidney after application of iodinated contrast media in rats. Invest Radiol. 2009;44:114-123.
19. Andersen KJ, Christensen EI, Vik H. Effects of iodinated X-ray contrast media on renal epithelial cells in culture. Invest Radiol. 1994;29:955-962.
20. Love L, Lind JA, Jr., Olson MC. Persistent ct nephrogram: Significance in the diagnosis of contrast nephropathy. Radiology. 1989;172:125-129.
21. Clanton TL. Hypoxia-induced reactive oxygen species formation in skeletal muscle. J Appl Physiol. 2007;102:2379-2388.
22. Shanley PF, Johnson GC. Oxygen metabolites and hypoxic renal injury: Effect of mitochondrial electron transport blockade. Ren Fail. 2002;24:249-258.
23. Kolyada AY, Liangos O, Madias NE, Jaber BL. Protective effect of erythropoietin against radiocontrast-induced renal tubular epithelial cell injury. Am J Nephrol. 2008;28:203-209.
24. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343:180-184.
25. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrastinduced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA. 2004;291:2328-2334.
26. Billings FT, Chen SW, Kim M, et al. Alpha2-adrenergic agonists protect against radiocontrast-induced nephropathy in mice. Am J Physiol Renal Physiol. 2008;295:741-748.
27. Barlak A, Akar H, Yenicerioglu Y, Yenisey C, Meteoglu I, Yilmaz O. Effect of sodium bicarbonate in an experimental model of radiocontrast nephropathy. Ren Fail. 2010;32: 992-999.
28. Lieberthal W, Nigam SK. Acute renal failure. Experimental models of acute renal failure: Imperfect but indispensable. Am J Physiol Renal Physiol. 2000;278:1-12.
29. Vari RC, Natarajan LA, Whitescarver SA, Jackson BA, Ott CE. Induction, prevention and mechanisms of contrast mediainduced acute renal failure. Kidney Int. 1988;33:699-707.
30. Ma X, Zhang BR, Li DT. Value of urinary kidney injury molecule-1 protein in early diagnosis of radiocontrast-induced nephropathy in rats. Nan Fang Yi Ke Da Xue Xue Bao. 2011;31:357-360.
31. Yesildag A, Ozden A, Yilmaz HR, et al. Erdosteine modulates radiocontrast-induced hepatotoxicity in rat. Cell Biochem Funct. 2009;27:142-147.
32. Dhanarajan R, Abraham P, Isaac B. Protective effect of ebselen, a selenoorganic drug, against gentamicin-induced renal damage in rats. Basic Clin Pharmacol Toxicol. 2006;99:267-272.
33. Hamacher J, Stammberger U, Weber E, Lucas R, Wendel A. Ebselen improves ischemia-reperfusion injury after rat lung transplantation. Lung. 2009;187:98-103.
34. Tunc T, Uysal B, Atabek C, et al. Erdosteine and ebselen as useful agents in intestinal ischemia/reperfusion injury. J Surg Res. 2009;155:210-216.
35. Pawlas N, Nierwinska K, Stolecka A, Gabryel B, Pudelko A, Malecki A. Effects of n-acetylcysteine and ebselen on arachidonic acid release from astrocytes and neurons cultured in normoxic or simulated ischemic conditions. Pharmacol Rep. 2009;61:941-946.
36. Husain K, Morris C, Whitworth C, Trammell GL, Rybak LP, Somani SM. Protection by ebselen against cisplatin-induced nephrotoxicity: Antioxidant system. Mol Cell Biochem. 1998;178:127-133.
37. Kizilgun M, Poyrazoglu Y, Oztas Y, et al. Beneficial effects of n-acetylcysteine and ebselen on renal ischemia/reperfusion injury. Ren Fail. 2011;33:512-517.